LEXICON PHARMACEUTICALS, INC. Inventory, Work in Process, Gross
LEXICON PHARMACEUTICALS, INC. (LXRX) had Inventory, Work in Process, Gross of $167.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2023-11-08
- 2023-09-30: Inventory, Work in Process, Gross $167.00K.
- 2023-06-30: Inventory, Work in Process, Gross $0.00.
- 2022-12-31: Inventory, Work in Process, Gross $0.00.
- 2020-06-30: Inventory, Work in Process, Gross $2.19M.
| Period end | Inventory, Work in Process, Gross | Inventory, Work in Process, Gross as first filed |
|---|---|---|
| 2023-09-30 | $167.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-04 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-08 | |
| 2020-06-30 | $2.19M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $1.12M 10-Q · filed 2020-04-27 | |
| 2019-12-31 | $200.00K 10-K · filed 2021-03-12 | $153.00K 10-K · filed 2020-03-12 |
| 2019-09-30 | $153.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $424.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $232.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $232.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $182.00K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $131.00K 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $131.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $149.00K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $41.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $25.00K 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |